GLBE vs. RIGL
GLBE (Global-e Online Ltd.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. GLBE operates in Internet Retail (Consumer Cyclical), while RIGL operates in Biotechnology (Healthcare). Over the past 5 years, GLBE returned -6.79%/yr vs -3.96%/yr for RIGL. At a 0.26 correlation, their price movements are largely independent.
Performance
GLBE vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLBE achieves a -16.74% return, which is significantly higher than RIGL's -23.30% return.
GLBE
- 1D
- -1.48%
- 1M
- 18.85%
- YTD
- -16.74%
- 6M
- -18.48%
- 1Y
- -1.59%
- 3Y*
- -4.73%
- 5Y*
- -6.79%
- 10Y*
- —
RIGL
- 1D
- 2.40%
- 1M
- 2.24%
- YTD
- -23.30%
- 6M
- -19.45%
- 1Y
- 54.23%
- 3Y*
- 27.10%
- 5Y*
- -3.96%
- 10Y*
- 3.28%
GLBE vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GLBE Global-e Online Ltd. | -16.74% | -27.91% | 37.60% | 92.01% | -67.44% | 161.40% |
RIGL Rigel Pharmaceuticals, Inc. | -23.30% | 154.64% | 16.00% | -3.33% | -43.40% | -17.70% |
Correlation
The correlation between GLBE and RIGL is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since May 12, 2021 | 0.26 |
Fundamentals
GLBE:
$5.70B
RIGL:
$646.69M
GLBE:
$0.67
RIGL:
$19.21
GLBE:
48.88
RIGL:
1.71
GLBE:
0.01
RIGL:
0.00
GLBE:
5.56
RIGL:
2.08
GLBE:
6.25
RIGL:
1.62
GLBE:
$1.02B
RIGL:
$299.77M
GLBE:
$467.05M
RIGL:
$279.95M
GLBE:
$146.46M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLBE vs. RIGL — Risk / Return Rank
GLBE
RIGL
GLBE vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global-e Online Ltd. (GLBE) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLBE | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.81 | ||
| Sortino ratioReturn per unit of downside risk | -1.35 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.20 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.05 | 1.09 | -1.14 |
| Martin ratioReturn relative to average drawdown | -0.11 | 1.91 | -2.02 |
Loading charts...
Drawdowns
GLBE vs. RIGL - Drawdown Comparison
The maximum GLBE drawdown since its inception was -79.10%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for GLBE and RIGL.
Loading charts...
Drawdown Indicators
| GLBE | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.10% | -99.37% | +20.27% |
Max Drawdown (1Y)Largest decline over 1 year | -33.78% | -50.08% | +16.30% |
Max Drawdown (3Y)Largest decline over 3 years | -56.17% | -57.75% | +1.58% |
Max Drawdown (5Y)Largest decline over 5 years | -79.10% | -85.24% | +6.14% |
Max Drawdown (10Y)Largest decline over 10 years | — | -86.40% | — |
Current DrawdownCurrent decline from peak | -59.93% | -96.93% | +37.00% |
Average DrawdownAverage peak-to-trough decline | -52.28% | -90.91% | +38.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.59% | 28.64% | -14.05% |
Volatility
GLBE vs. RIGL - Volatility Comparison
Global-e Online Ltd. (GLBE) has a higher volatility of 13.51% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 12.05%. This indicates that GLBE's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLBE | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.51% | 12.05% | +1.46% |
Volatility (6M)Calculated over the trailing 6-month period | 36.12% | 36.64% | -0.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.63% | 69.89% | -23.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.03% | 85.46% | -17.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.12% | 82.81% | -14.69% |
Dividends
GLBE vs. RIGL - Dividend Comparison
Neither GLBE nor RIGL has paid dividends to shareholders.
Financials
GLBE vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Global-e Online Ltd. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GLBE vs. RIGL - Profitability Comparison
GLBE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Global-e Online Ltd. reported a gross profit of 114.88M and revenue of 252.09M. Therefore, the gross margin over that period was 45.6%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
GLBE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Global-e Online Ltd. reported an operating income of 32.97M and revenue of 252.09M, resulting in an operating margin of 13.1%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
GLBE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Global-e Online Ltd. reported a net income of 30.36M and revenue of 252.09M, resulting in a net margin of 12.0%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
GLBE and RIGL have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLBE has higher volatility (13.51%) compared to RIGL (12.05%). In terms of maximum drawdown, GLBE dropped -79.10% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (0.78 vs -0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLBE and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer